Your New Role in the Battle Against Depression March 15, 2017 By Jill Sederstrom A shortage of mental health-care providers, coupled with pharmacists’ unique skills and access to patients, has led to a significant opportunity for community and health-system pharmacists to aid in detection of depression and in medication selection and counseling for patients with depression. Alzheimer's Disease: Untapped Potential for Pharmacy January 18, 2017 By Jill Sederstrom Pharmacists can become the perfect partner in the battle against Alzheimer’s disease. Details here. CE: New options when statins are not enough The goal of this activity is to prepare pharmacists with the knowledge they need to provide contemporary pharmacologic therapy to patients with hyperlipidemia. Key cogs in the management of Parkinson’s disease The goal of this activity is to assist pharmacists in managing difficult-to-treat symptoms of Parkinson’s disease. Are states going too far with painkiller script limits? December 06, 2016 By Christine Blank Arizona has become the latest state to limit opioid prescriptions—a trend that has some healthcare providers and experts concerned. A Class of Their Own: The Unique Challenges of Type I Diabetes November 11, 2016 By Jill Sederstrom While many aspects of diabetes care are universal, patients with type I diabetes (T1D) often face a unique set of obstacles and challenges. How Pharmacies are Helping Patients with Diabetes November 11, 2016 By Christine Blank When pharmacists get involved in patient care, significant improvements are often seen. Diabetes management is one of the most notable examples. Update on Diabetes Therapy November 10, 2016 By Monica Shah PharmD Despite evidence that optimal glycemic control can help reduce disease progression and complications, most patients do not achieve recommended treatment goals. Daclizumab approved for relapsing forms of multiple sclerosis Daclizumab is the first subcutaneous injectable monoclonal antibody to be approved for the treatment of MS.